Biochemical characterization of the antagonist actions of the xanthines, PACPX (1,3-dipropyl-8(2-amino-4-chloro)phenylxanthine) and 8-PT (8-phenyltheophylline) at adenosine A1 and A2 receptors in rat brain tissue

This publication has 12 references indexed in Scilit:

• Purine Receptors in Mammalian Tissues: Pharmacology and Functional Significance
  Annual Review of Pharmacology and Toxicology, 1987
• Adenosine A1 receptors in mammalian brain: Species differences in their interactions with agonists and antagonists
  Drug Development Research, 1986
• Effects of enprofylline and theophylline may show the role of adenosine
  Life Sciences, 1986
• Nomenclature of adenosine receptors
  Trends in Pharmacological Sciences, 1985
• Functionalized congeners of 1,3-dialkylxanthines: preparation of analogs with high affinity for adenosine receptors
  Journal of Medicinal Chemistry, 1985
• Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias
  Journal of the American College of Cardiology, 1985
• PACPX ‐ a substituted xanthine ‐ antagonizes both the A₁ and A₂ subclasses of the P₁‐purinoceptor: antagonism of the A₂ subclass is competitive but antagonism of the A₁ subclass is not
  British Journal of Pharmacology, 1985
• Psychiatric progress
  Journal of Psychiatric Research, 1984
• The role of adenosine in the regulation of coronary blood flow.
  Circulation Research, 1980
• Alkylxanthines: Inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity
  Life Sciences, 1979